Not finding it? Sign in to also search OpenAlex live.
-
MYF3001: A Randomized Open Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed/Refractory to Janus Kinase Inhibitor
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
2citations -
P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO EVALUATE IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS REFRACTORY TO JANUS KINASE INHIBITOR
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +11 more
1citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi)
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
1citations -
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature2020 Journal of Neurology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access
Maike Franziska Dohrn, Michaela Auer‐Grumbach, Ralf Baron, Frank Birklein, Fabiola Escolano‐Lozano, Christian Geber, +11 more
36citations -
Real-Time Nonlinear Model Predictive Control for the Energy Management of Hybrid Electric Vehicles in a Hierarchical Framework9citations
-
Fast Computation of Hydrodynamic Pressure in Lubricated Contacts: Which Lp Loss is Most Suitable for Physics-Informed Neural Networks Solving the Reynolds Equation?2024 International Journal of Fluid Power article Physics and Astronomy Model Reduction and Neural Networks Open access
Faras Brumand‐Poor, Nils Plückhahn, Niklas Bauer, Katharina Schmitz
2citations -
Expected costs and benefits of genetic counselling and germline genetic testing in metastatic prostate cancer2026 Human Genetics article Biochemistry, Genetics and Molecular Biology BRCA gene mutations in cancer Open access
Michiel Vlaming, Lambertus A.L.M. Kiemeney, Wouter Koole, Inge M. van Oort, Eveline M. A. Bleiker, Margreet G.E.M. Ausems, +1 more
0citations -
The Effects of Repetitive Use and Pathological Remodeling on Channelrhodopsin Function in Cardiomyocytes2021 Frontiers in Physiology article Neuroscience Photoreceptor and optogenetics research Open access
Balázs Ördög, Alexander S Teplenin, Tim De Coster, Cindy I. Bart, Sven O. Dekker, Juan Zhang, +3 more
9citations -
A scalable and equitable framework for target and patient prioritisation in rare disease antisense therapeutics2026 medRxiv preprint Biochemistry, Genetics and Molecular Biology Genomics and Rare Diseases Open access
Ella F. Whittle, Kylie Montgomery, Carme Camps, Nour M. Elkhateeb, Catherine Ryan, Sara Aguti, +26 more
1citations